Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...

Compared with systematic biopsy, MRI-directed targeted biopsy reduces the risk of overdiagnosis of prostate cancer for men with elevated prostate-specific antigen levels, according to researchers.

Excluding systematic biopsy in favor of MRI-targeted biopsy in men with elevated prostate-specific antigen (PSA) levels reduced the probability of detecting clinically insignificant cancers, but at ...

Researchers have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive ...

A Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way that can also spare low-yield and potentially harmful procedures. Yale ...

A Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way that can also spare low-yield and potentially harmful procedures. Yale ...

URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...

Writer Nick Harding has a blood test at a GFCT prostate cancer screening event at the Nelson Club in Warwick - Andrew Fox A few things are guaranteed to get men off the sofa and out the house.